RNA

News

  • Shering-Plough hepatitis C therapy FDA approved

    Shering-Plough hepatitis C therapy FDA approved

    SCHERING-PLOUGH today announced that the US Food and Drug Administration (FDA) has approved new labelling for its PEGINTRON (peginterferon alfa-2b) and REBETOL (ribavirin, USP) combination therapy for treating chronic hepatitis C in patients three years of age and older with compensated liver disease.

    16/03/2009

 

Products

 

Find more information about RNA on our other sites.

to get Medical Devices Equipment
delivered to your inbox

Latest from Twitter

    Getting your tweets...